Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

19.60
Delayed Data
As of Apr 25
 +0.05 / +0.26%
Today’s Change
11.85
Today|||52-Week Range
21.01
+40.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues52.3M89.7M109.6M138.9M
 
 
 
 
 
Depreciation And Amortization8.7M8.7M9.1M9.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses142.9M165.4M175.2M206.8M
 
 
 
 
 
Research And Development106.5M126.0M119.9M149.2M
 
 
 
 
 
Total Operating Expenses151.6M174.1M184.3M215.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-99.4M-84.4M-74.7M-77.1M
 
 
 
 
 
Extraordinary Credit0.000.0051.2M0.00
 
 
Extraordinary Charge0.000.000.00-15.5M
 
 
Other Expenses248.0K313.0K298.0K28.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-98.6M-83.3M-21.0M-88.1M
 
 
 
 
 
Net Income-98.6M-83.3M-21.0M-88.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.7M63.1M68.7M73.1M
 
 
 
 
 
Shares To Calculate EPS Diluted51.7M63.1M68.7M73.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.91-$1.32-$0.31-$1.20
 
 
 
 
 
EPS Diluted-$1.91-$1.32-$0.31-$1.20